Clinical trial
Main Trial of the Cesarean Section and Intestinal Flora of the Newborn Study
NCT04173208 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Main Trial of the Cesarean Section and Intestinal Flora of the Newborn Study
- Lead sponsor
- Helsinki University Central Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 10, 2019
- Completion date
- January 31, 2025
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cesarean section, affecting fetus or newborn, fecal microbiota transplantation, intestinal microbiome